Genocea Biosciences, Inc.
GNCADelisted Jun 2, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001457612
Genocea Biosciences, Inc. was delisted on Jun 2, 2022; its insiders filed their last Form 4 on Jun 3, 2022; 40 institutions reported holding it in 13F filings for Q1 2022, worth $42.1M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Genocea Biosciences, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +2 vs. Q3 2021
- Shares held
- 33.5M
- −284.2K (−0.8%) vs. Q3 2021
- Total value
- $38.9M
- −$26.0M (−40.1%) vs. Q3 2021
- New holders
- 6
- 7 more added
- Sold out
- 4
- 6 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $1 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $1 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 1 | $4.00K |
| Q2 2022 | 5 | $92.0K |
| Q1 2022 | 40 | $42.1M |
| Q4 2021 | 41 | $38.9M |
| Q3 2021 | 40 | $65.3M |
| Q2 2021 | 46 | $79.4M |
| Q1 2021 | 42 | $86.3M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Genocea Biosciences, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 1,037 | $1.00K | 0.00% | 00.0% | Unchanged |
| Artemis Wealth Advisors, LLC | 1,137 | $1.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 900 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,129 | $1.00K | 0.00% | +1,129 | New |
| First Manhattan Co | 2,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| ACT Capital Management, LLC | 5,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Vectors Research Management, LLC | 6,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,058 | $7.00K | 0.00% | +156+2.6% | Added |
| Wells Fargo & Company | 9,462 | $11.0K | 0.00% | −206−2.1% | Reduced |
| Empirical Asset Management, LLC | 10,000 | $12.0K | 0.01% | +10,000 | New |
| Capital Asset Advisory Services LLC | 11,766 | $14.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 13,636 | $15.0K | 0.00% | −2,033−13.0% | Reduced |
| Virtu Financial LLC | 12,503 | $15.0K | 0.00% | +12,503 | New |
| Personal Capital Advisors Corp | 15,000 | $17.0K | 0.00% | 00.0% | Unchanged |
| WealthTrust Axiom LLC | 15,000 | $17.0K | 0.01% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 16,305 | $19.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 19,684 | $23.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 19,916 | $23.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 21,741 | $25.0K | 0.00% | +21,741 | New |
| Two Sigma Advisers, LP | 22,677 | $26.0K | 0.00% | −119,800−84.1% | Reduced |
| Renaissance Technologies LLC | 27,500 | $32.0K | 0.00% | +27,500 | New |
| Simplex Trading, LLC | 31,015 | $35.0K | 0.00% | +31,015 | New |
| Commonwealth Equity Services, LLC | 31,981 | $37.0K | 0.00% | +10,576+49.4% | Added |
| Group One Trading, L.P. | 44,014 | $51.0K | 0.00% | −17,600−28.6% | Reduced |
| Bank of America Corp | 57,390 | $67.0K | 0.00% | +270.0% | Added |
| Northern Trust Corp | 70,837 | $82.0K | 0.00% | +14,368+25.4% | Added |
| BlackRock Inc. | 185,443 | $215.0K | 0.00% | +4,452+2.5% | Added |
| Millennium Management LLC | 196,433 | $228.0K | 0.00% | −180,912−47.9% | Reduced |
| Ikarian Capital, LLC | 196,821 | $228.0K | 0.07% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 206,880 | $239.0K | 0.00% | +20,938+11.3% | Added |
| HighTower Advisors, LLC | 212,260 | $246.0K | 0.00% | 00.0% | Unchanged |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $435.0K | 25.16% | 00.0% | Unchanged |
| Boxer Capital, LLC | 1,134,453 | $1.32M | 0.05% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,574,879 | $1.83M | 0.00% | +11,778+0.8% | Added |
| Citadel Advisors LLC | 1,795,495 | $2.08M | 0.00% | −58,331−3.1% | Reduced |
| Kingdon Capital Management, L.L.C. | 1,972,056 | $2.29M | 0.34% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 2,652,974 | $3.08M | 0.01% | 00.0% | Unchanged |
| Commodore Capital LP | 3,079,756 | $3.57M | 0.83% | 00.0% | Unchanged |
| BVF Inc | 4,012,404 | $4.65M | 0.17% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 5,084,184 | $5.90M | 0.10% | 00.0% | Unchanged |
| NEA Management Company, LLC | 10,376,936 | $12.0M | 0.24% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −57,836−100.0% | Sold out |
| First Republic Investment Management, Inc. | 0 | $0 | 0.00% | −12,285−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −625−100.0% | Sold out |
| Polaris Venture Management Co. V, L.L.C. | – | – | – | – | Not filed |